[1]邓 凯,许 薇,李 燕.缺血性脑卒中患者血浆vWF:Ag和S100B检测的临床意义[J].现代检验医学杂志,2017,32(05):52-54,58.[doi:10.3969/j.issn.1671-7414.2017.05.014]
　DENG Kai,XU Wei,LI Yan.Clinical Application of Detection of Plasma vWF:Ag and S100B in Ischemic Cerebral Apoplexy Disease[J].Journal of Modern Laboratory Medicine,2017,32(05):52-54,58.[doi:10.3969/j.issn.1671-7414.2017.05.014]
点击复制

缺血性脑卒中患者血浆vWF:Ag和S100B检测的临床意义()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第32卷
期数:
2017年05期
页码:
52-54,58
栏目:
论著
出版日期:
2017-11-02

文章信息/Info

Title:
Clinical Application of Detection of Plasma vWF:Ag and S100B in Ischemic Cerebral Apoplexy Disease
文章编号:
1671-7414(2017)05-052-04
作者:
邓 凯1; 许 薇1; 李 燕2
1.西安交通大学第一附属医院检验科,西安 710061; 2.咸阳市第一人民医院检验科,陕西咸阳 712000
Author(s):
DENG Kai1; XU Wei1; LI Yan2
1.Department of Clinical Laboratory,the First Affiliated Hospital of Xi'an Jiaotong University,X i'an 710061,China; 2.Department of Clinical Laboratory,the First People's Hospital of Xianyang City,Shaanxi Xianyang 712000,China
关键词:
缺血性脑卒中;  完全卒中;  不完全卒中;  血管性血友病因子抗原(vWF:Ag);  血浆钙连接蛋白B(S100B)
分类号:
R743.3; R446.111
DOI:
10.3969/j.issn.1671-7414.2017.05.014
文献标志码:
A
摘要:
目的 探讨血浆钙连接蛋白B(S100B)和血浆血管性血友病因子抗原(vWF:Ag)水平在缺血性脑卒中疾病中的临床应用价值。方法 收集85例于2014年1～10月在西安交通大学第一附属医院神经内科住院治疗的缺血性脑卒中患者的血液及临床资料,并从正常人群中随机抽取38例志愿者作为对照组。采用ELISA法检测所有研究对象的血浆S100B水平,使用Sysmex CA-7000全自动血凝仪检测其血浆vWF:Ag水平。采用 GELOGIC9型彩色多普勒超声诊断仪分析所有研究对象的颈动脉内径及内中膜厚度。将脑卒中症患者分为完全卒中(CS)组、不完全卒中(NCS)组,与对照组比较,观察血浆S100B和vWF:Ag水平变化与缺血性脑卒中疾病之间的关系。结果 血浆vWF:Ag(%)在CS组、NCS组和对照组的水平为176.8±56.3,128.9±37.6,93.7±30.1,血浆S100B水平(μg/L)为2.8±1.3,1.9±0.9,1.3±0.7。在CS组、NCS组和对照组中,各研究对象的颈动脉内径(mm)为(6.27±0.32,6.52±0.57,6.78±0.73,内中膜厚度(mm)为0.88±0.09,0.71±0.07,0.52±0.06。两病例组血浆vWF:Ag和S100B水平与对照组比较均增高,其差异均有统计学意义(F=125.9,89.3,均P<0.01); CS组与NCS组vWF:Ag和S100B比较显著增高,差异均有统计学意义(F=125.9,89.3,P<0.01)。CS组血浆vWF:Ag和S100B水平呈正相关(r=0.836,P<0.01),CS组的血浆vWF:Ag水平分别与颈动脉内径及内中膜厚度具有相关性(r=-0.853,0.923,P<0.01)。CS组的血浆S100B水平分别与颈动脉内径及内中膜厚度具有相关性(r=-0.820,0.833,P<0.01)。结论 检测vWF:Ag和S100B水平可预测缺血性脑卒中疾病发生的危险程度,估计病情的发展状况。
Abstract:
Abstract:Objective To explore the clinical application value of S100B and vWF:Ag levels in ischemic cerebral apoplexy disease.Methods The plasma and clinical data from 85 cases of patients with ischemic cerebral apoplexy were collected,extracted 38 cases of volunteer blood plasma from a random sample of the general population and quantitative detected S100B levels by ELISA method,using Sysmex CA-7000 automatic blood coagulation instrument to detect plasma vWF:Ag levels.The carotid artery diameter andintima-media thickness of all the participants were detected by GELOGIC9 colordoppler ultrasonic diagnostic instrument.Results The levels of plasma vWF:Ag in the CS group,the NCS(%)group and the control group were 176.8±56.3,128.9±37.6 and 93.7±30.1,which of plasma S100B(μg/L)were 2.8±1.3,1.9±0.9 and 1.3±0.7.Stroke patients could be divided into CSgroup and NCS group,compared with control group,observed the changes and the relationship of ischemic stroke disease for plasma S100B and vWF:Ag levels.Thelevels of plasma vWF:Ag and called S100B in the two case groups were increasedcompared with those in controls,the differences had statistical significance(F=125.9,89.3,P<0.01).In CS and NCS group,vWF:Ag and S100B were comparative differences and statistically significant(F=125.9,89.3,P<0.01),the levels of the two markers in the CS group were higher than in replication group.In CS group,the plasma levels of vWF:Ag and S100B were positively correlated(r=0.836,P<0.01).InCS group,plasma levels of vWF:Ag were associated with carotid artery diameterand intima-media thicknes(r=-0.853,0.923,P<0.01 and r=-0.783,0.823,P<0.01),which of S100B did so(r=-0.820,0.833,P<0.01).Conclution Detection of the levels of vWF:Ag and S100B can predict the degree of danger of ischemic cerebral apoplexy disease and estimate the development of the disease.

参考文献/References:

[1] 兰卫明,麻乐乐.缺血性脑卒中患者血清Chemerin因子表达及其临床意义[J].中国临床药理学杂志,2016,32(15):1353-1355. Lan WM,Ma LL.Expression and clinical significance of serum Chemerin in patients with ischemic stroke[J].Chinese Journal of Clinical Pharmacology,2016,32(15):1353-1355.
[2] 高宏娥,李荫桂,黄海云,等.缺血性脑卒中患者血浆脂蛋白相关磷脂酶A2测定的临床意义[J].现代检验医学杂志,2015,30(2):58-60,64. Gao HE,Li YG,Huang HY,et al.Clinical significance of plasma lipoprotein associated phospholipase A2 detecting in patients with ischemic cerebralstroke[J].Journal of Modern Laboratory Medicine,2015,30(2):58-60,64.
[3] 张立红,彭道勇,李 迪,等.老年缺血性脑卒中发病4.5h内患者重组组织型纤溶酶原激活剂静脉溶栓治疗转归不良的危险因素[J].中国老年学杂志,2014,34(23):6549-6551. Zhang LH,Peng DY,Li D,et al.The poor prognosis factors of intravenous thrombolysis with recombinant tissue-type plasminogen activator within 4.5h of ischemic stroke[J].Chinese Journal of Gerontology,2014,34(23):6549-6551.
[4] 刘竞丽,秦 超.缺血性脑卒中血液生物标志物的检测及临床应用[J].中华检验医学杂志,2014,37(7):497-500. Liu JL,Qin C.Clinical application of blood biomarkers in ischemicstroke[J].Chinese Journal of Laboratory Medicine,2014,37(7):497-500.
[5] 沈显群,龚自力.血清高迁移率族蛋白B1,白细胞介素-18和-23S100B及同型半胱氨酸和神经肽Y水平检测对缺血性脑卒中预后的影响[J].中国实用神经疾病杂志,2015,18(19):16-18. Shen XQ,Gong ZL.Effect on the prognosis of ischemic cerebral apoplexy in detection?of serum interleukin-18 and 23 of high migration rate proteinB1,S100B and homocysteine and neuropeptide Y levels[J].Chinese Journal of Practical Nervous Disease,2015,18(19):16-18.
[6] Astrand R,Unden J,Romner B.Clinical use of the calcium binding S100B protein[J].Methods Mol Bio,2013(963):373-384.
[7] 景增秀.缺血性脑卒中患者血清中S100B、半乳糖凝集素-3和神经元特异性烯醇化酶的表达及意义[J].中国老年学杂志,2016,36(3):623-625. Jing ZX.The clinical significance and expression of serum S100B,Ghemerin-3 and neuronspecific enolase in ischemic cerebral apoplexy[J].ChineseJournal of Gerontology,2016,36(3):623-625.
[8] 张 琦,耿 洁,赵建国,等.急性脑梗死患者血浆Hcy,hs-CRP,vWF检测的临床意义[J].国际检验医学杂志,2014,35(18):2444-2445. Zhang Q,Geng J,Zhao JG,et al.Clinical significance of plasma Hcy,hs-CRP and vWF determination in patients with acute cerebral infarction[J].International Journal of Laboratory Medicine,2014,35(18):2444-2445.
[9] 张 熊,任旭爱.vWF:Ag,D-二聚体,t-PA,PAI-1和BNP检测在风湿性心脏病中的应用价值[J].中国医师杂志,2013,15(5):648-650. Zhang X,Ren XA.Application value of detection of VWF:Ag,D-dimer,t-PA and PAI-1 and BNP in rheumatic heart disease[J].Journal of Chinese Physician,2013,15(5):648-650.

相似文献/References:

[1]马 炜,朱 俊,徐 健,等.NLR与缺血性脑卒中患者预后关系研究[J].现代检验医学杂志,2016,31(04):139.[doi:10.3969/j.issn.1671-7414.2016.04.043]
　MA Wei,ZHU Jun,XU Jian,et al.Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis for Acute Ischemic Stroke[J].Journal of Modern Laboratory Medicine,2016,31(05):139.[doi:10.3969/j.issn.1671-7414.2016.04.043]
[2]张 艳a,刘 翔a,李鸿钏a,等.血清脂蛋白磷脂酶A2 和血浆抗凝血酶Ⅲ对2 型糖尿病患者发生缺血性脑卒中风险的评估价值[J].现代检验医学杂志,2020,35(04):71.[doi:10.3969/j.issn.1671-7414.2020.04.017]
　ZHANG Yana,LIU Xianga,LI Hong-chuana,et al.Evaluation Value of Serum Lipoprotein-Associated Phospholipase A2 and Plasma Antithrombin Ⅲ on the Risk of Ischemic Stroke in Patients with Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2020,35(05):71.[doi:10.3969/j.issn.1671-7414.2020.04.017]
[3]利荣乔.血清Galectin-3和HDL-C水平检测对急性缺血性脑卒中预后的影响研究[J].现代检验医学杂志,2021,36(05):128.[doi:10.3969/j.issn.1671-7414.2021.05.029]
　LI Rong-qiao.Effect of Serum Galectin-3 and HDL-C Levels on Prognosis of AcuteIschemic Stroke[J].Journal of Modern Laboratory Medicine,2021,36(05):128.[doi:10.3969/j.issn.1671-7414.2021.05.029]
[4]杜龙庭,勿坡巫且,许春梅,等.缺血性脑卒中患者血清miR-155和PDCD4mRNA表达水平与颈动脉支架成形术后再狭窄的相关性研究[J].现代检验医学杂志,2022,37(02):105.[doi:10.3969/j.issn.1671-7414.2022.02.022]
　DU Long-ting,WUPO Wu-qie,XU Chun-mei,et al.Correlation between the Expression of miR-155, PDCD4 mRNA and Restenosis after Carotid Artery Stenting in Patients with Cerebral Ischemic Stroke[J].Journal of Modern Laboratory Medicine,2022,37(05):105.[doi:10.3969/j.issn.1671-7414.2022.02.022]
[5]何 涛a,孔德强a,韩雪飞a,等.缺血性脑卒中患者行颈动脉支架成形术前血清CCR5，SDF-1 mRNA 表达水平与术后支架内再狭窄的相关性研究[J].现代检验医学杂志,2022,37(06):171.[doi:10.3969/j.issn.1671-7414.2022.06.033]
　HE Taoa,KONG De-qianga,HAN Xue-feia,et al.Correlation between Serum CCR5, SDF-1 mRNA Expression Levels and Postoperative In-stent Restenosis in Patients with Ischemic Stroke before Carotid Artery Stenting[J].Journal of Modern Laboratory Medicine,2022,37(05):171.[doi:10.3969/j.issn.1671-7414.2022.06.033]
[6]王桂瑜,欧阳葵,苏小田,等.缺血性脑卒中患者血清LncRNA MEG8 表达水平及临床价值研究[J].现代检验医学杂志,2023,38(04):105.[doi:10.3969/j.issn.1671-7414.2023.04.019]
　WANG Guiyu,OUYANG Kui,SU Xiaotian,et al.Expression Level of Serum LncRNA MEG8 and Its Clinical Significance in Patients with Ischemic Stroke[J].Journal of Modern Laboratory Medicine,2023,38(05):105.[doi:10.3969/j.issn.1671-7414.2023.04.019]
[7]高继英a,石代乐b,王 刚c.缺血性脑卒中患者血清LncRNA SNHG8 的表达及临床意义[J].现代检验医学杂志,2023,38(05):75.[doi:10.3969/j.issn.1671-7414.2023.05.014]
　GAO Jiyinga,SHI Daileb,WANG Gangc.Expression and Clinical Significance of Serum LncRNA SNHG8 in Patients with Ischemic Stroke[J].Journal of Modern Laboratory Medicine,2023,38(05):75.[doi:10.3969/j.issn.1671-7414.2023.05.014]

备注/Memo

备注/Memo:
作者简介:邓 凯(1987-),男,本科,检验师,主要从事脑卒中的实验室诊断研究,E-mail:dengkai611@163.com。
更新日期/Last Update: 1900-01-01